SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-20-000055
Filing Date
2020-11-05
Accepted
2020-11-05 06:07:01
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnce-20200930.htm   iXBRL 10-Q 1615272
2 EX-31.1 q32020exhibit311.htm EX-31.1 10660
3 EX-31.2 q32020exhibit312.htm EX-31.2 10626
4 EX-32.1 q32020exhibit321.htm EX-32.1 6162
5 EX-32.2 q32020exhibit322.htm EX-32.2 6087
11 cnce-20200930_g1.jpg GRAPHIC 159960
  Complete submission text file 0001367920-20-000055.txt   6817104

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20200930.xsd EX-101.SCH 37964
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20200930_cal.xml EX-101.CAL 71118
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20200930_def.xml EX-101.DEF 201089
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20200930_lab.xml EX-101.LAB 538195
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20200930_pre.xml EX-101.PRE 341192
12 EXTRACTED XBRL INSTANCE DOCUMENT cnce-20200930_htm.xml XML 1028961
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 201288478
SIC: 2834 Pharmaceutical Preparations